GATD1-DT: A Drug Target / Disease Biomarker (G171391)

GATD1-DT: A Drug Target / Disease Biomarker

GATD1-DT is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 16 and is responsible for the production of a protein known as GATD1-DT.

GATD1-DT is a transmembrane protein that is expressed in a variety of tissues throughout the body, including the brain, heart, and gastrointestinal tract. It is known for its role in the development and progression of various diseases, including cancer.

One of the most promising aspects of GATD1-DT is its potential as a drug target. By targeting the GATD1-DT protein, researchers and pharmaceutical companies may be able to develop new treatments for a variety of diseases.

GATD1-DT has been shown to be involved in a number of important biological processes, including cell signaling, angiogenesis, and inflammation. It is also known for its role in the development and progression of various diseases, including cancer.

Studies have shown that GATD1-DT is often overexpressed or hypermethylated in a variety of cancer types, which may contribute to its involvement in these diseases. This suggests that targeting GATD1-DT may be a promising strategy for the development of new treatments for cancer and other diseases.

In addition to its potential as a drug target, GATD1-DT is also a potential biomarker. By measuring the level of GATD1-DT in tissues or fluids, researchers may be able to monitor the effectiveness of different treatments and determine the potential for new treatments.

GATD1-DT is also a potential target for other diseases, including cardiovascular disease and autoimmune disorders. Studies have shown that GATD1-DT is involved in the development and progression of these diseases, which may make it an attractive target for new treatments.

Overall, GATD1-DT is a promising gene for the development of new drugs and biomarkers. Further research is needed to fully understand its role in various diseases and to develop effective treatments.

Protein Name: GATD1 Divergent Transcript

More Common Targets

GATD3 | GATM | GATOR1 Complex | GAU1 | GBA1 | GBA2 | GBA3 | GBAP1 | GBE1 | GBF1 | GBGT1 | GBP1 | GBP1P1 | GBP2 | GBP3 | GBP4 | GBP5 | GBP6 | GBP7 | GBX1 | GBX2 | GC | GCA | GCAT | GCC1 | GCC2 | GCC2-AS1 | GCDH | GCFC2 | GCG | GCGR | GCH1 | GCHFR | GCK | GCKR | GCLC | GCLM | GCM1 | GCM2 | GCN1 | GCNA | GCNT1 | GCNT1P3 | GCNT2 | GCNT3 | GCNT4 | GCNT7 | GCOM1 | GCSAM | GCSAML | GCSAML-AS1 | GCSH | GCSHP3 | GCSIR | GDA | GDAP1 | GDAP1L1 | GDAP2 | GDE1 | GDF1 | GDF10 | GDF11 | GDF15 | GDF2 | GDF3 | GDF5 | GDF6 | GDF7 | GDF9 | GDI1 | GDI2 | GDI2P1 | GDNF | GDNF Family Receptor alpha | GDNF-AS1 | GDPD1 | GDPD2 | GDPD3 | GDPD4 | GDPD5 | GDPGP1 | GEM | GEMIN2 | GEMIN4 | GEMIN5 | GEMIN6 | GEMIN7 | GEMIN8 | GEMIN8P1 | GEMIN8P4 | GEN1 | general transcription factor IIF (TFIIF) | General transcription factor IIH | Geranylgeranyl transferase | Geranylgeranyl transferase type-1 | GET1 | GET3 | GET4 | GFAP | GFER